Kymera Therapeutics Company
Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.
Technology:
Others
Industry:
PharmTech
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
1/1/2017
Employees Number:
101-250
Funding Status:
IPO
Total Funding:
454000000
Estimated Revenue:
$1M to $10M
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership